Inventor

KRANTZ ALEXANDER

US27 patents

⚠️ This page may combine multiple inventors who share the name “KRANTZ ALEXANDER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KRANTZ ALEXANDER

SYNTEX INC

Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors

4H-3,1-benzoxazin-4-ones and related compounds and use as enzyme inhibitors

Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors

Transglutaminase inhibitors

3,5-substituted 4,5-dihydroisoxazoles as transglutaminase inhibitors

2-oxy-4H-3,1-benzoxazin-4-ones and related compounds and pharmaceutical use

2-oxy-4H-3,1-benzoxazin-4-ones and pharmaceutical use

Ynenolactone protease inhibitors

Matrix metalloprotease inhibitors

α-allenic-α-amino acids as enzyme inhibitors

Novel use for carbamoyl benzoates

γ-allenyl-γ-aminobutyric acids

Matrix metalloprotease inhibitors

CONJUCHEM INC

Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes

Extended lifetimes in vivo renin inhibitors

Methods for producing novel conjugates of thrombin inhibitors

Affinity labeling libraries with tagged leaving group

Affinity labeling libraries and applications thereof

KRANTZ ALEXANDER

Site-specific modification of proteins through chemical modification enabling protein conjugates, protein dimer formation, and stapled peptides

Crosslinking of proteins and other entities via conjugates of α-haloacetophenones, benzyl halides, quinones, and their derivatives

Site-specific chemical modification of proteins at their N-termini, enabling the formation of homogeneous adducts

Site-selective functionalization of proteins using traceless affinity labels

ADVANCED PROTEOME THERAPEUTICS INC

Site-specific labeling and targeted delivery of proteins for the treatment of cancer

Composition and method for modifying polypeptides

Tandem analyses of noncovalently driven effectors for modulatory mapping of activities of protein sites

REDCELL CANADA INC

Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes

CONJUCHEM BIOTECHNOLOGIES INC

Affinity markers for human serum albumin